Results 161 to 170 of about 5,410,565 (209)

Molecular Characterization of Sterol C4-Methyl Oxidase in <i>Leishmania major</i>. [PDF]

Int J Mol Sci
Ning Y, Basu S, Hsu FF, Feng M, Wang MZ, Zhang K.   +5 more
europepmc   +1 more source

Antigen recognition reinforces regulatory T cell mediated Leishmania major persistence. [PDF]

Nat Commun, 2023
Zayats R, Mou Z, Yazdanpanah A, Gupta G, Lopez P, Nayar D, Koh WH, Uzonna JE, Murooka TT.   +8 more
europepmc   +1 more source

Natural Product Identification and Molecular Docking Studies of Leishmania Major Pteridine Reductase Inhibitors. [PDF]

Pharmaceuticals (Basel)
Arthur MN, Hanson G, Broni E, Sakyi PO, Mensah-Brown H, Miller WA, Kwofie SK.   +6 more
europepmc   +1 more source

Correction: Antileishmanial effect of podophyllotoxin and podophyllin on Leishmania major in vitro and in vivo. [PDF]

J Parasit Dis
Ghayour AH, Delavari M, Arbabi M.
europepmc   +1 more source

Virulent or avirulent (dhfr-ts−)Leishmania majorelicit predominantly a type-1 cytokine response by human cellsin vitro [PDF]

, 2000
Cláudia Brodskyn, Stephen M. Beverley, Richard G. Titus   +2 more
openalex   +1 more source

Comment on "A New Immunogenic Structure of Polyepitopic Fusion against Leishmania major: In Silico Study". [PDF]

Iran J Parasitol
Majidiani H, Hosseini SA.
europepmc   +1 more source

Recombinase-based amplification coupled with lateral flow chromatography for the specific and sensitive detection and identification of Leishmania major in cutaneous leishmaniasis patients. [PDF]

Front Microbiol
Bel Hadj Ali I, Saadi-Ben Aoun Y, Khammeri I, Souguir H, Harigua-Souiai E, Chouaieb H, Chakroun AS, Lemrani M, Kallel A, Kallel K, Haddad N, El Dbouni O, Coler RN, Reed SG, Fathallah-Mili A, Guizani I.   +15 more
europepmc   +1 more source

Therapeutic effect of topical tamoxifen in murine cutaneous leishmaniasis caused by <i>Leishmania major</i>. [PDF]

Antimicrob Agents Chemother
Hassani-Abharian P, Hejazi Dehaghani S, Shahmoradi Z, Hejazi SH.   +3 more
europepmc   +1 more source

Contribution of epidermal growth factor (EGF) in the treatment of cutaneous leishmaniasis caused by Leishmania major in BALB/c mice. [PDF]

PLoS Negl Trop Dis
Saberi M, Latifi A, Golkar M, Fard-Esfahani P, Mohtasebi S, Teimouri A, Abbaszadeh Afshar MJ, Kazemirad E, Mohebali M, Mohebali M.   +9 more
europepmc   +1 more source

Immunoinformatic approach to the design of a novel multi-epitope vaccine against Leishmania major fused to human IgG-Fc. [PDF]

Res Pharm Sci
Fadaie M, Shahmoradi Z, Khanahmad H.
europepmc   +1 more source